These findings highlight the differential impact of HIF2A mutations on HIF2A-VHL interaction with higher HIF2A levels implicated in tumorigenesis (class 1 disease) as opposed to slight increases in HIF2A activity that are sufficient to induce erythrocytosis in class 2 disease [52]. Here, EPAS1 is linked to polycythemia.